Live
AgilentAgilent Technologies (A) Announces Transition of Chief Legal Off - GuruFocusAgilentHow Investors May Respond To Agilent Technologies (A) CRISPR Patent Setback And New BioTek Cytation 9 Launch - Yahoo FinanceAgilentAgilent Technologies announces transition of chief legal officer Bret DiMarco - investing.comAgilentAgilent (NYSE: A) details Chief Legal Officer transition and advisory role - Stock TitanIlluminaCathie Wood's Called It Years Ago – Illumina Is the Must-Own Personalized Biotech Stock - Money MorningFierceBiotechTrump slaps 100% duties on imported drugs but leaves plenty of exceptionsFierceBiotechBiopharma R&D pipeline shrinks for 1st time in 30 years: reportFierceBiotechADCs, TCEs among ‘exciting things’ on Boehringer’s dealmaking shopping listFierceBiotechMonths after $100M series A, Syneron closes $150M round to support peptide platformBioPharma DiveTrump revives pharma tariffs with 100% charges, but leaves loopholesPLoS BiologyHow the brain copes with bad timesThermo FisherThermo Fisher Scientific introduces Gibco™ CTS™ Compleo™ Fill and Finish System - BioSpectrum Asia
BioWorld Feb 11, 2026

NIH ends Xarelto arm of stroke trial due to safety, futility

NIH ends Xarelto arm of stroke trial due to safety, futility

Original
Body unavailable. Use the original source.

Directory

59 All